Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 124 for transplant

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

    Rochester, MN, Jacksonville, FL

  2. Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

    Rochester, MN

  3. HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

    Rochester, MN

  4. A Study to Evaluate the Safety and Effectiveness of Autologous Cells Expressing Anti-CD20 and Anti-CD19 in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection

    Rochester, MN

  6. Coping with Hematopoietic Stem Cell Transplantation and Psychosocial

    Scottsdale/Phoenix, AZ

  7. Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured from Deceased Donors with High Kidney Donor Profile Index (KDPI)

    Jacksonville, FL

  8. A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation (FREEDOM-1)

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

    Jacksonville, FL

  10. Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas

    Rochester, MN

.

Mayo Clinic Footer